Skip to content
healthcare.dev

Montelukast Sodium

NDC 57237-212, Montelukast Sodium, tablet, chewable, from Rising Pharma Holdings, Inc..

Product NDC
57237-212
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202096
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57237-212 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MONTELUKAST SODIUM4 mg/1

Pharmacologic classes

Leukotriene Receptor Antagonist [EPC]; Leukotriene Receptor Antagonists [MoA]

Package NDCNDC-11Package
57237-212-305723702123030 TABLET, CHEWABLE in 1 BOTTLE (57237-212-30)
57237-212-905723702129090 TABLET, CHEWABLE in 1 BOTTLE (57237-212-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/49669ac0-0bb5-4576-bed5-9e85e0d76a44
  • NADAC price for package 57237021230

    GET /v1/drugs/nadac/57237021230
  • NADAC price for package 57237021290

    GET /v1/drugs/nadac/57237021290

Use it

Look up 57237-212 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57237-212 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57237-212. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.